Overview

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study is to see whether treating diabetic retinal swelling with ranibizumab injections into the eye monthly is better than treating diabetic retinal swelling with ranibizumab injections into the eye less frequently.
Phase:
Phase 2
Details
Lead Sponsor:
Retina Vitreous Associates of Florida
Collaborator:
Genentech, Inc.
Treatments:
Ranibizumab